Specificity of serine proteinase/serpin complex binding to very-low-density lipoprotein receptor and α2-macroglobulin receptor/low-density-lipoprotein-receptor protein

European Journal of Biochemistry

Volumn 248, Issue 2, 1997, Pages 270-281

  Kasza, Aneta ^a,b   Petersen, Helle H ^a   Heegaard, Christian W ^a   Oka, Kazuhiro ^c   Christensen, Anni ^a   Dubin, Adam ^b   Chan, Lawrence ^c   Andreasen, Peter A ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Low density lipoprotein receptor related protein; Plasminogen activator; Serine proteinase; Serpin; Very low density lipoprotein receptor

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 2 ANTIPLASMIN; ANTITHROMBIN III; CATHEPSIN G; COMPLEMENT COMPONENT C1S INHIBITOR; ELASTASE; HEPARIN COFACTOR II; KALLIKREIN; LEUKOCYTE ELASTASE; LIPOPROTEIN RECEPTOR; PLASMIN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 3; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; THROMBIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL STRAIN COS1; CHO CELL; CONTROLLED STUDY; DRUG COMPARISON; ENDOCYTOSIS; GENE EXPRESSION; HUMAN; IMMUNOBLOTTING; IN VITRO STUDY; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; EQUUS CABALLUS;

EID: 0030886795     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1997.00270.x     Document Type: Article

References (71)

1. Andreasen, P. A., Georg, B., Lund, L. R., Riccio, A. & Stacey, S. N. (1990) Plasminogen activator inhibitors. Hormonally regulated serpins, Mol. Cell. Endocrinol. 68, 1-19.
2. Andreasen, P. A., Sottrup-Jensen, L., Kjøller, L., Nykjær, A., Moestrup, S. K., Petersen, C. M. & Gliemann, J. (1994) Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes, FEBS Lett. 338, 239-245.
3. Andreasen, P. A., Kjøller, L., Christensen, L. & Duffy, M. J. (1997) The urokinase-type plasminogen activator system in cancer metastasis. A review, Int. J. Cancer 72, 1-22.
4. Argraves, K. M., Battey, F. D., MacCalman, C. D., McCrae, K. R., Gåfvels, M., Kozarsky, K. F., Chappell, D. A., Strauss, J. F. & Strickland, D. K. (1995) The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes, J. Biol. Chem. 270, 26550-26557.
5. Battey, F. D., Gåfvels, M. E., FitzGerald, D. J., Argraves, W. S., Chappell, D. A., Strauss, J. F. & Strickland, D. K. (1994) The 39 kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor, J. Biol. Chem. 269, 23268-23273.
6. Baugh, R. J. & Travis, J. (1976) Human leukocyte granule elastase: rapid isolation and characterization, Biochemistry 15, 836-841.
7. de Boer, H. C., de Groot, P. G. & Preissner, K. T. (1993) Metabolism of vitronectin complexes, in Biology of vitronectins and their receptors (Preissner, K. T., Rosenblatt, S., Kost, C., Wegerhoff, J. & Mosher, D. F., eds) pp. 103-110, Elsevier Science Publishers, Amsterdam.
8. 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator, Proc. Natl Acad. Sci. USA 89, 7427-7431.
9. Bujo, H., Hermann, M., Kaderli, M. O., Jacobsen, L., Sugawara, S., Nimpf, J., Yamamoto, T. & Schneider, W. J. (1994) Chicken oocyte growth is mediated by an eight ligand binding repeat member of the LDL receptor family, EMBO J. 13, 5165-5175.
10. Carrell, R. W. & Stein, P. E. (1996) The biostructural pathology of the serpins: critical function of sheet opening mechanism, Biol. Chem. Hoppe-Seyler 377, 1-17.
11. 2-macroglobulin receptor in human breast carcinomas, Int. J. Cancer 66, 441-452.
12. Christie, R. H., Chung, H., Rebeck, G. W., Strickland, D. & Hyman, B. T. (1996) Expression of the very low density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease, J. Neuropathol. Exp. Neurol. 55, 491-498
13. 2plasmin inhibitor, Eur. J. Biochem. 120, 105-112.
14. 2-macroglobulin receptor, J. Bioil. Chem. 269, 17886-17892.
15. Danø, K., Møller, V., Ossowski, L. & Nielsen, L. S. (1980) Purification and characterization of a plasminogen activator from mouse cells transformed by an oncogenic virus, Biochim. Biophys. Acta 613, 542-555.
16. Dubin, A. (1977) A polyvalent proteinase inhibitor from horse-blood-leucocyte cytosol, Eur. J. Biochem. 73, 429-435.
17. Dubin, A., Potempa, J. & Travis J. (1990) Isolation of nine human plasma proteinase inhibitors by sequential affinity chromatography, Prep. Biochem. 20, 63-74.
18. Ehrlich, H. J., Gebbink, R. K., Keijer, J. & Pannekoek, H. (1992) Elucidation of structural requirements on plasminogen activator inhibitor 1 for binding to heparin, J. Biol. Chem. 267, 11606-11611.
19. 2-macroglobulin-methylamine, Biochim. Biophys. Acta 716, 151-157.
20. 2MR/LRP). Binding and endocytosis of fluid phase and membrane-associated ligands, Ann. N.Y. Acad. Sci. 737, 20-38.
21. 2-antiplasmin-protease complexes in mice, Thromb. Haemostasis 48, 208-210.
22. Heegaard, C. W., Simonsen, A. C. W., Oka, K., Kjøller, L., Christensen, A., Madsen, B., Ellgaard, L., Chan, L. & Andreasen, P. A. (1995) Very low density lipoprotein receptor binds and mediates endocytosis of urokinase-type plasminogen activator-type-1 plasminogen activator inhibitor complex, J. Biol. Chem. 270, 20855-20861.
23. 1-antitrypsin for structure and function of serpins, Biochemistry 28, 8951-8966.
24. Jensen, P. H., Christensen, E. I., Ebbesen, P., Gliemann, J. & Andreasen, P. A. (1990) Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells, Cell Regul. 1, 1043-1056.
25. 1-antitrypsin-protease complexes, J. Biol. Chem. 266, 11282-11288.
26. 1AT, Biol Chem. 268, 1886-1893.
27. Kim, D.-H., Iijama, H., Goto, K., Sakai, J., Ishii, H., Kim, H.-J., Suzuki, H., Kondo, H., Saeki, S. & Yamamoto, T. (1996) Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain, J. Biol. Chem. 271, 8373-8380.
28. 2-macroglobulin receptor and urokinase receptor expression, Mol. Cell. Endocrinol. 109, 209-217.
29. Knauer, D. J., Thompson, J. A. & Cunningham, D. D. (1983) Protease nexins: Cell-secreted proteins that mediate the binding, internalization, and degradation of regulatory serine proteases, J. Cell. Physiol. 117, 385-396.
30. 2-Macroglobulin receptor/low density lipoprotein receptor-related protein mediates cellular uptake of pro-urokinase, J. Biol. Chem. 268, 21862-21867.
31. 1-antitrypsin complexes is mediated by the low density lipoprotein receptor-related protein, J. Biol. Chem. 271, 6523-6529.
32. Kruithof, E. K., Baker, M. S. & Bunn, C. L. (1995) Biological and clinical aspects of plasminogen activator inhibitor type 2, Blood 86, 4007-4024.
33. Laurell, M., Carlson, T. H. & Stenflo, J. (1988) Monoclonal antibodies against the heparin dependent protein C inhibitor suitable for inhibitor purification and assay of inhibitor complexes. Thromb. Haemostasis 60, 334-339.
34. Lollar, P. & Owen, W. G. (1980) Clearance of thrombin from circulation in rabbits by high-affinity binding sites on endothelium, J. Clin. Invest. 66, 1222-1230.
35. 1 40000 receptor associated protein, Eur. J. Biochem., in the press.
36. 2-antiplasmin, angiotensinogen, and ovalbumin, Biochemistry 30, 1723-1730.
37. 2-macroglobulin receptor containing a cluster of eight complement-type repeats, J. Biol. Chem. 268, 13691-13696.
38. 2-macroglobulin receptor and epithelial glycoprotein-330. Two giant receptors mediating endocytosis of multiple ligands, Biochim. Biophys. Acta 1197, 197-213.
39. Multhaupt, H. A. B., Gåfvels, M. E., Kariko, K., Jin, H., Arenas-Elliott, C., Goldman, B. I., Strauss, J. F. III, Angelin, B., Warhol, M. J. & McCrae, K. R. (1996) Expression of very low density lipoprotein receptor in the vascular wall. Analysis of human tissues by in situ hybridization and immunohistochemistry. Am. J. Pathol. 148, 1985-1997.
40. Munch, M., Heegaard, C. W. & Andreasen, P. A. (1993) Interconversions between active, inert and substrate forms of denatured/refolded type-1 plasminogen activator inhibitor, Biochim. Biophys. Acta 1202, 29-37.
41. Nielsen, L. S., Andreasen, P. A., Grøndahl-Hansen, J., Huang, J.-Y., Kristensen, P. & Danø, K. (1986) Monoclonal antibodies to human 54000 molecular weight plasminogen activator inhibitor from fibro-sarcoma cells - inhibitor neutralization and one-step affinity purification, Thromb. Haemostasis. 55, 206-212.
42. Novak, S., Hiesberger, T., Schneider, W. J. & Nimpf, J. (1996) A new low density lipoprotein receptor homologue with 8 ligand binding repeats in brain of chicken and mouse, J. Biol. Chem. 271, 11732-11736.
43. 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes, J. Biol. Chem. 267, 14543-14546.
44. 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase agains binding to the endocytic receptor, J. Biol. Chem. 269, 25668-25676.
45. Oka, K., Tzung, K. W., Sullivan, M., Lindsay, E., Baldini, A. & Chan, L. (1994) Human very low density lipoprotein receptor complementary DNA and deduced amino acid sequence and localization of its gene (VLDLR) to chromosome band 9p24 by fluorescence in situ hybridization. Genomics 20, 298-300.
46. Okuizumi, K., Onodera, O., Namba, Y., Ikeda, K., Yamamoto, T., Seki, K., Ueki, A., Nanko, S., Tanaka, H., Takahashi, H., Oyanagi, K., Mizusawa, H., Kanazawa, I. & Tsuji, S. (1995) Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nature Genetics 11, 207-209.
47. 2-macroglobulin receptor. Proc. Natl Acad. Sci. USA 89, 7422-7426.
48. Perlmutter, D. H., Glover, G. I., Rivetna, M., Schasteen, C. S. & Fallon, R. J. (1990a) Identification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes. Proc. Natl Acad. Sci. USA 87, 3753-3757.
49. 1-antitrypsin-protease complexes is mediated by the serpin-enzyme complex (SEC) receptor, J. Biol. Chem. 265, 16713-16716.
50. 1-proteinase inhibitor, antithrombin III and heparin cofactor II, Biochim. Biophys. Acta 967, 158-162.
51. 1-antichymotrypsin-cathepsin G complexes by the low density lipoprotein receptor-related protein, J. Biol. Chem. 270, 2841-2845.
52. Potempa, J., Korzus, E. & Travis, J. (1994) The serpin superfamily of proteinase inhibitors: structure, function, and regulation, J. Biol. Chem. 269, 15957-15960.
53. Pratt, C. W., Church, F. C. & Pizzo, S. V. (1988) In vivo catabolism of heparin cofactor II and its complex with thrombin: evidence for a common receptor-mediated clearance pathway for three serine proteinase inhibitors, Arch. Biochem. Biophys. 262, 111-117.
54. Pratt, C. W. & Church, F. C. (1992) Heparin binding to protein C inhibitor, J. Biol. Chem. 267, 8789-8794.
55. Redlitz, A. & Plow, E. F. (1995) Receptors for plasminogen and t-PA: an update, Baillieres Clin. Haematol. 8, 313-327.
56. Sakai, J., Hoshino, A., Takahashi, S., Miura, Y., Ishii, H., Suzuki, H., Kawarabayasi, Y. & Yamamoto, T. (1994) Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene, J. Biol. Chem. 269, 2173-2182.
57. Schulze, A. J., Huber, R., Bode, W. & Engh, R. A. (1994) Structural aspects of serpin inhibition, FEBS Lett. 344, 117-124.
58. r 40000 receptor associated protein, FEBS Lett. 354, 279-283.
59. Stefansson, S., Lawrence, D. A. & Argraves, W. S. (1996) Plasminogen activator inhibitor-1 and vitronectin promote the cellular clearance of thrombin by low density lipoprotein receptor-related proteins-1 and 2. J. Biol. Chem. 271, 8215-8220.
60. Stubbs, M. T. & Bode, W. (1994) Coagulation factors and their inhibitors. Current Opin. Struct. Biol. 4, 823-832.
61. Strickland, D. K., Kounnas, M. Z., Williams, S. E. & Argraves, W. S. (1994) LDL receptor-related protein (LRP). A multiligand receptor, Fibrinolysis 8 (suppl. 1), 204-215.
62. Suzuki, J., Takahashi, S., Oida, K., Shimada, A., Kohno, M., Tamai, T., Miyabo, S., Yamamoto, T. & Nakai, T. (1995) Lipid accumulation and foam cell formation in Chinese hamster ovary cells overexpressing very low density lipoprotein receptor, Biochem. Biophys. Res. Commun. 206, 835-842.
63. Takahashi, S., Kawarabayasi, Y., Nakai, T., Sakai, J. & Yamamoto, T. (1992) Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity, Proc. Natl Acad. Sci. USA 89, 9252-9256.
64. Takahashi, S., Suzuki, J., Kohno, M., Oida, K., Tamai, T., Miyabo, S., Yamamoto, T. & Nakai, T. (1995) Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase, J. Biol. Chem. 270, 15747-15754.
65. Takeya, H., Hamada, T., Kume, M. & Suzuki, K. (1994) Receptor-mediated endocytosis of thrombin-antithrombin III complex by the human monocytoid cell line U937, Biochem. Biophys. Res. Commun. 200, 1334-1340.
66. Watorek, W., van Halbeek, H. & Travis, J. (1993) The isoforms of human neutrophil elastase and cathepsin G differ in their carbohydrate side chain structures, Biol. Chem. Hoppe-Seyler 374, 385-393.
67. Webb, J. C., Patel, D. D., Jones, M. D., Knight, B. L. & Soutar, A. K. (1994) Characterization and tissue-specific expression of the human very low density lipoprotein receptor mRNA, Hum. Mol. Genet. 3, 531-537.
68. Willnow, T. E., Goldstein, J. L., Orth, K., Brown, M. S. & Herz, J. (1992) Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance, J. Biol. Chem. 267, 26172-26180.
69. Willnow, T. E., Orth, K., Brown, M. S. & Herz, J. (1994) Molecular dissection of ligand binding sites on the low density lipoprotein receptor-related protein, J. Biol. Chem. 269, 15827-15832.
70. Wittmaack, F. M., Gåfvels, M. E., Bronner, M., Matsuo, H., McCrae, K. R., Tomaszewski, J. E., Robinson, S. L., Strickland, D. K. & Strauss, J. F. III (1995) Localization and regulation of the human very low density lipoprotein/apolipoprotein-E receptor. Trophoblast expression predicts a role for the receptor in placenta lipid transport, Endocrinology 136, 340-348.
71. Wyne, K. L., Pathak, R. K., Seabra, M. C. & Hobbs, H. H. (1996) Expression of the VLDLR receptor in endothelial cells, Arterioscler. Thromb. Vasc. Biol. 16, 407-415.